ArticleFrontiers in public health2021

Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis.

Xiaoyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.